Erin F. Barreto, Pharm.D., R.Ph.

  • Pharmacist, Mayo Clinic Hospital — Rochester
  • Assistant Professor of Medicine and Pharmacy, Mayo Clinic College of Medicine and Science

What moment or experience in your life influenced your decision to be a pharmacist?

As with many health care professionals, my interest in pharmacy stemmed from an eagerness to help people. In the intensive care unit in which I work, pharmacists are an integral part of the multidisciplinary team that seeks to deliver high-quality care in a fast-paced environment. Each day I get to bear witness to the positive impact that team collaboration can have on patients' outcomes and experiences.

What motivated you to become a Kern Health Care Delivery Scholar?

Instead of treating one patient at a time, research allows clinicians to disseminate knowledge and expertise that can improve the care of many patients at once. As a Kern Scholar, I look forward to combining didactic education with career development opportunities and hands-on mentorship so I can use research to more broadly affect care delivery.

What is your focus as a scholar within the Mayo Clinic Kern Center for the Science of Health Care Delivery?

My focus as a Kern Scholar is to determine the circumstances in which a new approach to drug dosing for hospitalized patients using a novel kidney function marker, cystatin C, is clinically appropriate, effective and economically feasible.

What is your mentoring team like?

My mentoring team is a multidisciplinary group of dedicated researchers and clinicians who represent the disciplines of nephrology and hypertension, critical care medicine, and health sciences research.

How will your research improve patient care or impact public health?

Many medications used routinely in the hospital setting are in large part eliminated through the kidney and therefore require dose adjustments in the setting of kidney dysfunction.

Clinicians expect that when they select a drug dose based on a patient's kidney function from the recommended options, it will be both safe for the patient and effective for the condition they are treating. Yet the existing tools to assess kidney function render this assumption invalid.

By developing and translating new cystatin C-based drug dosing models into practice, I hope to give clinicians a way to more safely and effectively use medications to improve care.

Why did you choose Mayo Clinic to pursue your career?

Mayo Clinic offers unparalleled opportunities for personal and professional growth at a world-class facility. I was naturally drawn to the chance to grow as a clinician, educator and researcher in an innovative, patient-centered environment.